European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting

This meeting brings together the members of the Patients and Consumers Working Party (PCWP) and the Healthcare Professionals Working Party (HCPWP).

• Date:
  Teisipäev, 2 juuli 2024, All day
  Kolmapäev, 3 juuli 2024, All day
• Asukoht:
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

This meeting brings together the members of the Patients and Consumers Working Party (PCWP) and the Healthcare Professionals Working Party (HCPWP).

Documents

Agenda - European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting

Draft Reference Number: EMA/187783/2024

Meeting summary - European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting (July 2024)

Reference Number: EMA/308177/2024

Presentation - HMA/EMA task force on availability of authorised medicines (I. Abed, EMA)

Presentation - Joint HMA/EMA big data steering group on real-world evidence (RWE) methods (Klaus Kruttwig, EMA)

Presentation - HMA/EMA task force on availability of authorised medicines (J. Ferreira, EMA)

Presentation - EMA’s vaccines outreach strategy (M. Cavaleri, M. Carr, EMA)

Presentation - European vaccination information portal (EVIP) (N. White, ECDC)

Presentation - EU vaccine monitoring platform what is it, and how can it inform HCPs, patients, and the public, on the benefit/risk of vaccines (C. Cohet, A. Buoninfante, EMA)

Presentation - HCPO: Roles and Responsibilities of the GP in Prescribing in the Health Care System (M. McCarthy, UEMO)

Presentation - Clinical trials raw data pilot – interim results (F. Pétavy and M. Rückbeil EMA)

Presentation - Extension of the EMAN strategy to 2028 (M. Carr, EMA)

Presentation - Update on ACT EU and Multistakeholder Platform (Ana Zanoletty, EMA) (Denis Lacombe, EORTC)

Presentation - Update of the QRD template of the package leaflet (Monica Buch, EMA)

Presentation - Concept paper on the revision of the Guideline on Risk Assessment of Medicinal Products on Human Reproduction and Lactation: from Data to Labelling (Dinah Duarte, EMA)

Presentation - Re-start of Clinical Data Publication – Update on transparency activities (Silvia GarridoLestache, EMA)

Presentation - Revised CTIS transparency rules and new version of the public portal

Presentation - Outcome of biosimilars surveys to patients, healthcare professionals, industry and HMA (R. G. Quevedo, EMA - D. de Cock, EMA)

Presentation - Activities of the European Network Chessmen (N. Simoes, Infarmed) (D. Di Giorgio, AIFA)